Biotech entity
Every one of those 1 sits in a single category, pharma. APGO automated insulin delivery algorithm is most often covered alongside 300U Tubeless Patch Pump, which appears in 1 of these 1 story. APGO automated insulin delivery algorithm appears in 1 tracked Biotech story from July 27, 2026.
Last mentioned: Jul 27, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. APGO automated insulin delivery algorithm is most often covered alongside 300U Tubeless Patch Pump, which appears in 1 of these 1 story. APGO automated insulin delivery algorithm appears in 1 tracked Biotech story from July 27, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering APGO automated insulin delivery algorithm. Shared-story counts are live from our verified record — not editorial picks.
Medtrum is advancing its 300U tubeless insulin pump toward the German market, leveraging its in-house APGO automated insulin delivery algorithm. The device’s reimbursement listing in Germany could pressure competitors like Insulet and Medtronic in the automated diabetes management space. Biopharma investors should watch for clinical evidence and partnership developments.
Source: manilatimes.net · prnewswire.com
APGO automated insulin delivery algorithm is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
